The medical technology (MedTech) industry helps provide healthcare across the United States. Recently, tariffs on imported medical devices and parts have put financial pressure on hospitals, healthcare systems, and manufacturers. These tariffs, along with rising labor costs and reimbursement rates that do not keep up with inflation, are changing how MedTech companies and healthcare providers work. Hospital administrators, medical practice owners, and IT managers need to understand these problems to manage in a market that is getting more complicated and expensive.
Recent data shows that economic problems have made many medical device companies rethink their work. According to the 2025 Medical Device Industry Report, over one-third of these companies stopped hiring, and many larger firms reduced their workforce. These changes happened because costs went up and funding became harder to get. Tariffs on imported medical supplies range from 10% on many goods to 145% on products from China. These tariffs caused worry. The extra costs made companies delay creating new products and putting in new technology that could make care better and faster.
Matt McFarlane, who studies these trends, said companies are trying to cut costs because of these financial pressures. This is necessary but has downsides. Scott Whitaker, President and CEO of AdvaMed, told the U.S. Senate Finance Committee that tariffs could hurt supply chains and make lifesaving devices cost more. He supports trade agreements without tariffs to keep prices lower and ensure access to important healthcare tools.
Hospitals and healthcare systems especially feel the impact of rising MedTech supply costs. Labor is the biggest part of hospital budgets, making up 56% of total costs. Registered nurse salaries have grown 26.6% faster than inflation in the last four years. At the same time, Medicare pays hospitals only 83 cents for every dollar they spend. This led to an underpayment of over $100 billion in 2023 alone.
This money problem limits hospitals’ ability to buy new devices and technologies that could improve care. Administrative costs went up too, with hospitals spending $26 billion in 2023 on managing insurance claims. This was a 23% increase from 2022. Tasks like prior authorizations and claim denials cause delays and make care coordination harder.
The problem is worse in rural and medically underserved areas, where providers have tighter budgets and fewer supply options. A survey by Black Book Market Research found that 80% of healthcare workers expect hospital costs to rise by at least 15% in six months due to tariffs. These cost increases could slow innovation and limit patient access to newer medical technologies. This might cause longer wait times and lower quality care for patients.
Tariffs have disrupted global supply chains, causing delays and higher production costs. Medical devices like remote patient monitoring (RPM) systems depend on imported parts like semiconductors and sensors from Asia. Higher tariffs have increased hardware costs and forced companies to rethink their supplier agreements. Some have moved production to the U.S., even though this costs more.
Switching suppliers can also slow FDA approvals or require extra testing, which makes product launches take longer. Smaller companies and startups have a harder time because they have less money and resources. For example, Tenovi uses multiple supply sources in different countries to reduce reliance on China and avoid price swings.
Hospitals, which already have tight budgets, are careful about spending. Value Analysis Committees in healthcare systems look closely at the clinical and financial benefits before buying new devices. This cautious approach affects current buying decisions and delays future tech purchases.
Groups like AdvaMed have asked for tariff exceptions on medical and dental devices. They have sent formal requests to government trade officials. Their coalition includes the American Hospital Association and other healthcare groups. These organizations say tariffs hurt innovation, supply chain stability, and patient care quality.
New laws like the Access to Prescription Digital Therapeutics Act of 2025 try to help by improving Medicare and Medicaid coverage for proven digital treatments. The Ensuring Patient Access to Critical Breakthrough Products Act aims to speed up Medicare coverage for new devices to help patients get faster access.
Still, delays from regulatory agencies like the FDA are a worry. Staff cuts and departures have slowed approval processes, especially for new technologies. These delays and rising costs make it harder for MedTech companies to succeed.
In this difficult situation, healthcare administrators and IT managers are using artificial intelligence (AI) and workflow automation to keep running smoothly. Tools that automate front-office jobs, like AI answering phones, reduce administrative work. Companies like Simbo AI provide these automation tools to help improve patient communication and lower staff costs.
AI phone systems can manage appointment scheduling, handle patient questions, and do routine follow-ups without putting too much strain on staff. This lets nurses and receptionists focus on patient care. AI also reduces mistakes and ensures patients get messages on time. This helps hospitals manage patient flow, even when supplies or money are tight.
AI systems can also handle supplier information, order tracking, and compliance documents. This cuts down on paperwork, which costs hospitals billions every year. It speeds up approvals and billing too.
By using AI in their work, hospitals can become stronger against the financial pressures caused by tariffs and higher costs. This technology makes work more efficient and improves patient satisfaction and coordination.
The MedTech industry faces many connected problems in 2025. Tariffs raise costs and cause supply chain delays. Hospitals struggle with high labor costs and low reimbursements. Regulatory delays add to the financial issues. These problems slow the adoption of new technology but also show the need for smarter, automated solutions.
Healthcare providers, especially in underserved areas, must handle these challenges carefully. Using AI automation and integrated tech platforms may help cut administrative costs and make workflows smoother. At the same time, leaders in the industry keep pushing for policies that reduce tariff costs and improve supply chain stability.
For medical practice managers, owners, and IT leaders, staying aware of these economic trends and new automation tools is key to keeping quality care going during this difficult time.
Medical device companies are navigating economic uncertainty, which has led to hiring freezes, reduced headcount, and delays in new product development and technology investments.
Current tariffs, particularly those on medical supplies, threaten to disrupt supply chains and increase costs, putting financial pressure on healthcare providers and potentially impacting patient outcomes.
Companies are delaying technology investments that could enhance productivity due to economic conditions, risking inefficiencies and higher long-term costs.
Many companies still rely on general-purpose software and paper-based systems for clinical trials and other processes, indicating a need for modernization.
Delaying technology upgrades can lead to inefficiencies and overwhelming data management challenges as companies move closer to product launch.
It’s advised to equip teams with the right tools to maintain efficiency in a volatile economy, focusing on streamlined processes and reducing chaos.
Greenlight Guru assists companies by integrating quality management, product development, and supplier management into a single platform to enhance organizational efficiency.
Funding has emerged as the biggest hurdle for carrying out clinical trials, complicating the development process.
More than a third of companies have halted hiring, with nearly half of those with over 1,000 employees reducing their workforce.
Despite uncertainties, there remains cautious optimism about the industry’s potential, although economic pressures are expected to slow growth.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
